Home

Read time: 4 minutes  Young adults (less than 50 years of age) are being diagnosed with lung cancer at increasing rates. They tend to be women of Hispanic or Asian descent and are typically diagnosed with advanced-stage lung cancer. Research is ongoing to help us develop effective

Read time: 3 minutes  In Part 1 of a 3-part Advocacy 101 series, the LUNGevity Action Network presents a conversation with longtime advocate and lung cancer survivor Jill Feldman.   Register today for Part 2, Advocacy 101: Research Advocacy, and join us on June 17 at 2pm

On May 16, 2024, the US Food and Drug Administration (FDA) announced the accelerated approval of tarlatamab-dlle (Imdelltra®) to treat patients with extensive stage small cell lung cancer (SCLC).  This targeted immunotherapy, the first of its kind, is based on new technology. Tarlatamab is

Read time: 5 minutes  At 77 years old, a persistent cough prompted Lola Boyle to visit her doctor on multiple occasions, but her smoking history and diagnoses of COPD and emphysema led the doctor to dismiss it. “You have a cough because you’re a smoker,” he said. This wasn’t enough for

Read time: 2 minutes Integrative oncology adds holistic approaches—such as acupuncture, nutrition, exercise, and mindfulness—into a treatment plan. Research shows these interventions can have a tremendous impact on people going through lung cancer treatment and their quality of life.

Read time: 4 minutes  Lung cancers that test positive for the RET biomarker are often treated with targeted therapy. While this type of treatment has improved the duration and quality of life for many people living with lung cancer, we know that eventually these tumor cells develop

Read time: 4 minutes Advances in targeted therapies have allowed us to treat some types of lung cancer with mutations in specific genes (for example, EGFR, KRAS, and RET). This has given some patients with lung cancer a better quality of life and longer survival. However, even after an

Read time: 7 minutes It’s spring! The daffodils bloom, the days become longer, and I attend the annual meeting of the American Association for Cancer Research (AACR). For those of you who are new to this meeting, it is the largest gathering of laboratory scientists and clinicians in the

Read time: 5 minutes  For National Volunteer Week, we’re shining a light on the many volunteers who make our programs and events possible. From Breathe Deep TOGETHER to Team LUNGevity, the LUNGevity Action Network, and beyond, thank you to everyone who volunteers their time to help

Kathy Giusti joined LUNGevity for a special conversation about her life as a cancer patient, caregiver, and the founder and former CEO of the Multiple Myeloma Research Foundation. Her involvement with the medical system from these different perspectives inspired her to write her recent book, Fatal

Read time: 3 minutes  Tom Moser wrote the words below based on years of experience caring for his wife, Mary Lynn, who had lung and breast cancer and has since passed away. Prior to her passing, Mary Lynn authored a separate blog encouraging readers to be both mentees and mentors, as

Read time: 3 minutes  Mary Lynn Moser, with her husband and caregiver, Tom, wrote the words below before her passing. She was a supporter of LUNGevity and served as a mentor to others experiencing lung cancer. Her message encourages others to be “thrivers” and mentors in their lung